Amgen

Amgen Cancer Drugs Slow March of Deadly Tumors, Studies Suggest
Bloomberg
Thu, 05/20/10 - 06:29 pm
Amgen
cancer
pancreatic cancer
ovarian cancer
conatumumab
Biosimilars Aren't So Darn Easy
Seeking Alpha
Wed, 05/19/10 - 10:36 am
biosimilars
Merck
Amgen
Health-Care Reform Hits Drugmakers' (and Your) Pockets
Motley Fool
Tue, 05/18/10 - 09:31 pm
healthcare reform
Eli Lilly
Biogen Idec
Gilead Sciences
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Pfizer
Merck
Amgen (AMGN) Submits BLA to U.S. FDA for Denosumab RANK Inhibitor
Street Insider
Mon, 05/17/10 - 10:36 am
Amgen
BLA
FDA
denosumab
RANK Ligand inhibitor
Merck's Ditching of Aranesp Biosimilar Highlights Follow-on-Biologics Pitfalls
Seeking Alpha
Mon, 05/17/10 - 09:57 am
follow-on biologics
Aranesp
Merck
Amgen
Teva Pharmaceuticals
anemia
Amgen Submits Denosumab Biologics License Application to FDA for the Reduction of Skeletal Related Events in Cancer Patients
Amgen, PR NewsWire
Sat, 05/15/10 - 11:51 am
Amgen
denosumab
Bone metastases
Will Adaptive Design Change The BioPharma World?
Investopedia
Fri, 05/14/10 - 08:31 am
adaptive design
Amgen
Gilead Sciences
Eli Lilly
Pfizer
InterMune
Are Health-Care Stocks a Buy?
Motley Fool
Thu, 05/13/10 - 06:53 am
JNJ
Pfizer
Merck
Amgen
drug stocks
Abbott Laboratories
Q1 Results, Healthcare Reforms Provide Pharma Opportunity to Downplay Expectations
Seeking Alpha
Mon, 05/10/10 - 09:17 am
earnings
Abbott Laboratories
Amgen
Eli Lilly
Merck
Pfizer
Sanofi
Will Biosimilars Alter Biotech Landscape?
Seeking Alpha
Tue, 05/4/10 - 10:47 am
biotech
biosimilars
FDA
Amgen
Genentech
Genzyme
Make Money From 2020's Blockbuster Drugs
Motley Fool
Tue, 04/27/10 - 09:33 pm
Abbott Laboratories
Amgen
Bristol-Myers Squibb
Sanofi
Novartis
Pfizer
AstraZeneca
Amylin
Merck
Novo Nordisk
No Drug Can Cure the Health-Care Reform Infection
Motley Fool
Thu, 04/22/10 - 08:12 pm
Enbrel
Pfizer
healthcare reform
earnings
Neulasta
Amgen
Neupogen
Humira
Abbott Laboratories
Remicade
Merck
JNJ
Health-Care Overhaul and Drugmaker Outlook: Amgen
WSJ Online
Thu, 04/22/10 - 10:18 am
healthcare reform
Amgen
earnings
Eli Lilly
Gilead Sciences
JNJ
Abbott Laboratories
Amgen reports higher profit, increased sales
Marketwatch
Thu, 04/22/10 - 06:42 am
Amgen
earnings
Better, Targeted Drugs, Dead Ahead
Motley Fool
Wed, 04/21/10 - 07:53 am
personalized medicine
Vectibix
Amgen
Novartis
Bristol-Myers Squibb
Eli Lilly
OSI Pharmaceuticals
ONYX Pharmaceuticals
Roche
Analysts see possible revenue surprise for Amgen's 1st quarter, look ahead to Prolia
Yahoo/AP
Mon, 04/19/10 - 05:54 pm
earnings
Prolia
Amgen
What’s Ahead for Biotech Earnings
Minyanville
Sat, 04/17/10 - 12:11 pm
biotech
earnings
Amylin
Gilead Sciences
Biogen Idec
Amgen
Genzyme
Drug Companies' Rebellion Against "Abusive" Lawsuits Could Strip Investors of More Rights
BNET Pharma
Thu, 04/15/10 - 08:50 am
investors
lawsuits
Amgen
Abbott Laboratories
Allergan
Biotech Earnings: Large-Cap Preview
TheStreet.com
Wed, 04/14/10 - 10:46 am
earnings
Amylin
Biogen Idec
Gilead Sciences
Vanda
Genzyme
Amgen
Alexion
Celgene
Allos
Which drugs will be pharma's top 2014 blockbusters?
Fierce Pharma
Tue, 04/13/10 - 10:43 am
Avastin
Humira
Roche
Pfizer
Amgen
Enbrel
Lantus
Sanofi
Novo Nordisk
Novolog

Pages